Capital World Investors
SRRA

Capital World Investors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Capital World Investors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-490,809
Closed -$27M – 583
2022
Q2 		$27M Buy
+490,809
New +$25.8M 0.01% 444

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Capital World Investors's SRRA Position: Q3 2022 in Review

Capital World Investors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 490,809 shares — an estimated $27M sold.

Capital World Investors first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $27M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Capital World Investors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Capital World Investors sold 490,809 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $27M.
  • Capital World Investors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Capital World Investors's Sierra Oncology, Inc. Common Stock position peaked at $27M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.